Venture capital firm profile

Lund-based venture capital fund supporting life science and technology companies.
Nordics and Europe, with Scandinavia as home base.
Typically €1M–€6M per company over time, often in milestone-based tranches. Series B investments are selective.
Companies can submit a pitch through the form or by email.
These pages were saved for the profile. They have not been mapped to individual claims.
Nordics and Europe, with Scandinavia as home base.
Sources checked
Primarily commercial-stage companies, typically Seed to Series A; selectively Series B.
Sources checked
Typically €1M–€6M per company over time, often in milestone-based tranches. Series B investments are selective.
Sources checked
Specific supporting source not yet mapped.
Companies can submit a pitch through the form or by email.
Sources checked
Disclosed stages: Seed, Series A, Series B. Disclosed sectors: Healthcare and life sciences. Investment geography: Nordics; Europe. Typically €1M–€6M per company over time, often in milestone-based tranches. Series B investments are selective.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Loading recent changes…